新诺威(300765.SZ)：筹划发行H股股票并在香港联合交易所上市

Core Viewpoint - The company, XinNuoWei (300765.SZ), is advancing its globalization strategy by planning to apply for an initial public offering (IPO) of overseas listed shares (H-shares) on the Hong Kong Stock Exchange to enhance its core competitiveness in international markets and promote the development of its pharmaceutical business [1] Group 1 - The company will hold the 26th meeting of the sixth board of directors and the 21st meeting of the sixth supervisory board on September 30, 2025, to review and approve the proposal for the IPO [1] - The decision aims to create an international capital operation platform [1] - The initiative is part of the company's efforts to deepen its global strategic layout [1]